Aurora Luminarium dried flower

Aurora Luminarium is a premium medicinal cannabis product specifically formulated as a high-THC sativa dried flower. The product is originally bred and developed in Canada by Aurora Cannabis Inc., where the brand was founded in 2006 by entrepreneurs Terry Booth and Steve Dobler in Edmonton, Alberta.

Manufacturing takes place primarily in Canada at Aurora's advanced cultivation facilities, which are designed to meet strict pharmaceutical standards (EU-GMP) for international export. In New Zealand, the product is distributed by Indica Industries Ltd, which acts as the local partner following a significant strategic expansion by the parent company into the Australasian market.

As of 2026, the brand remains under the ultimate ownership of Aurora Cannabis Inc., a publicly traded global leader in the cannabinoid industry headquartered in Canada. The company maintains a strong international presence, serving patients across Canada, Europe, and Oceania, and recently solidified its regional operations by acquiring MedReleaf Australia (formerly a subsidiary of Indica Industries) to streamline its distribution network.